- Hem
- Böcker
- Kurslitteratur
- Vård, Omsorg & Medicin
- Statistical Thinking for Non-Statisticians in Drug Regulation (inbunden, eng)
Statistical Thinking for Non-Statisticians in Drug Regulation (inbunden, eng)
STATISTICAL THINKING FOR NON-STATISTICIANS IN DRUG REGULATION Statistical methods in the pharmaceutical industry are accepted as a key eleme...
919 kr
965 kr
Bara 2 kvar
Skickas inom 2-3 vardagar
- Fri frakt
Fri frakt över 299:-
Snabb leverans
Alltid låga priser
Produktbeskrivning
STATISTICAL THINKING FOR NON-STATISTICIANS IN DRUG REGULATION Statistical methods in the pharmaceutical industry are accepted as a key element in the design and analysis of clinical studies. Increasingly, the medical and scientific community are aligning with the regulatory authorities and recognizing that correct statistical methodology is essential as the basis for valid conclusions.
In order for those correct and robust methods to be successfully employed there needs to be effective communication across disciplines at all stages of the planning, conducting, analyzing and reporting of clinical studies associated with the development and evaluation of new drugs and devices.
Statistical Thinking for Non-Statisticians in Drug Regulation provides a comprehensive in-depth guide to statistical methodology for pharmaceutical industry professionals, including physicians, investigators, medical science liaisons, clinical research scientists, medical writers, regulatory personnel, statistical programmers, senior data managers and those working in pharmacovigilance.
The author’s years of experience and up-to-date familiarity with pharmaceutical regulations and statistical practice within the wider clinical community make this an essential guide for the those working in and with the industry. The third edition of Statistical Thinking for Non-Statisticians in Drug Regulation includes: A detailed new chapter on Estimands in line with the 2019 Addendum to ICH E9Major new sections on topics including Combining Hierarchical Testing and Alpha Adjustment, Biosimilars, Restricted Mean Survival Time, Composite Endpoints and Cumulative Incidence Functions, Adjusting for Cross-Over in Oncology, Inverse Propensity Score Weighting, and Network Meta-AnalysisUpdated coverage of many existing topics to reflect new and revised guidance from regulatory authorities and author experience Statistical Thinking for Non-Statisticians in Drug Regulation is a valuable guide for pharmaceutical and medical device industry professionals, as well as statisticians joining the pharmaceutical industry and students and teachers of drug development.
In order for those correct and robust methods to be successfully employed there needs to be effective communication across disciplines at all stages of the planning, conducting, analyzing and reporting of clinical studies associated with the development and evaluation of new drugs and devices.
Statistical Thinking for Non-Statisticians in Drug Regulation provides a comprehensive in-depth guide to statistical methodology for pharmaceutical industry professionals, including physicians, investigators, medical science liaisons, clinical research scientists, medical writers, regulatory personnel, statistical programmers, senior data managers and those working in pharmacovigilance.
The author’s years of experience and up-to-date familiarity with pharmaceutical regulations and statistical practice within the wider clinical community make this an essential guide for the those working in and with the industry. The third edition of Statistical Thinking for Non-Statisticians in Drug Regulation includes: A detailed new chapter on Estimands in line with the 2019 Addendum to ICH E9Major new sections on topics including Combining Hierarchical Testing and Alpha Adjustment, Biosimilars, Restricted Mean Survival Time, Composite Endpoints and Cumulative Incidence Functions, Adjusting for Cross-Over in Oncology, Inverse Propensity Score Weighting, and Network Meta-AnalysisUpdated coverage of many existing topics to reflect new and revised guidance from regulatory authorities and author experience Statistical Thinking for Non-Statisticians in Drug Regulation is a valuable guide for pharmaceutical and medical device industry professionals, as well as statisticians joining the pharmaceutical industry and students and teachers of drug development.
Format | Inbunden |
Omfång | 432 sidor |
Språk | Engelska |
Förlag | John Wiley and Sons Ltd |
Utgivningsdatum | 2022-12-29 |
ISBN | 9781119867388 |
Specifikation
Böcker
- Inbunden, 432, Engelska, John Wiley And Sons Ltd, 2022-12-29, 9781119867388
Leverans
Vi erbjuder flera smidiga leveransalternativ beroende på ditt postnummer, såsom Budbee Box, Early Bird, Instabox och DB Schenker. Vid köp över 299 kr är leveransen kostnadsfri, annars tillkommer en fraktavgift från 29 kr. Välj det alternativ som passar dig bäst för en bekväm leverans.
Betalning
Du kan betala tryggt och enkelt via Avarda med flera alternativ: Swish för snabb betalning, kortbetalning med VISA eller MasterCard, faktura med 30 dagars betalningstid, eller konto för flexibel delbetalning.
Specifikation
Det finns tyvärr inga specifikationer att visa för denna produkt.